EC Number |
Inhibitors |
Structure |
---|
6.3.5.7 | (1R,2R)-1-(4-methylsulfonylphenyl)-2-(S-dioxo-L-methioneamido)-1,3-propanediol |
- |
|
6.3.5.7 | (1R,2R)-1-(4-nitrophenyl)-2-(S-dioxo-L-methioneamido)-1,3-propanediol |
- |
|
6.3.5.7 | (1R,2R)-1-phenyl-2-(S-dioxo-L-methioneamido)-1,3-propanediol |
- |
|
6.3.5.7 | (1R,2S)-1-(4-nitrophenyl)-2-(S-dioxo-L-methioneamido)-1,3-propanediol |
- |
|
6.3.5.7 | (1S,2R)-1-(4-nitrophenyl)-2-(S-dioxo-L-methioneamido)-1,3-propanediol |
- |
|
6.3.5.7 | (1S,2S)-1-(4-nitrophenyl)-2-(S-dioxo-L-methioneamido)-1,3-propanediol |
- |
|
6.3.5.7 | 2'-O-(trinitrophenyl)adenosine 5'-triphosphate |
IC50: 2.4 mM |
|
6.3.5.7 | 3'-(L-alpha-aspartylamino)-3'-deoxy-N,N-dimethyladenosine |
puromycin analogue |
|
6.3.5.7 | 3'-deoxy-3'-(L-alpha-glutamylamino)-N,N-dimethyladenosine |
puromycin analogue |
|
6.3.5.7 | 3'-deoxy-3'-(L-glutaminylamino)-N,N-dimethyladenosine |
puromycin analogue |
|